Literature DB >> 17286059

2006 ISSVD classification of vulvar dermatoses: pathologic subsets and their clinical correlates.

Peter J Lynch1, Micheline Moyal-Barracco, Micheline Moyal-Barrocco, Fabrizio Bogliatto, Leonardo Micheletti, James Scurry.   

Abstract

The International Society for the Study of Vulvovaginal Disease (ISSVD) has, as one of its major societal goals, the development and promulgation of nomenclature and classification of vulvar disease. A committee of the ISSVD has developed new nomenclature and classification for the specific area of vulvar dermatoses. This classification was approved by the ISSVD members at the most recent international congress, held in New Zealand in February 2006.

Entities:  

Mesh:

Year:  2007        PMID: 17286059

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  [Establishment of a rat model of dimethylbenzanthracene-induced vulvar squamous intraepithelial lesions].

Authors:  Yijin Fan; Huajun Tang; Yao Liu; Chengzhi Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

2.  Lichen sclerosus in breast cancer survivor.

Authors:  Pedro Vieira-Baptista
Journal:  J Gen Intern Med       Date:  2013-03       Impact factor: 5.128

3.  [Establishment of a SD rat model of vulvar lichen simplex chronicus and detection of the expression of protease activated receptor 2].

Authors:  Huan Yang; Zhen-Hua Fu; Hua-Jun Tang; Cheng-Zhi Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

4.  The Clinicopathologic Challenge of Nonneoplastic Vulvar Acanthosis.

Authors:  Tania Day; James Scurry; Gholamreza Haqshenas; Gerald Murray; Hong Tran; Graeme Dennerstein; Suzanne M Garland
Journal:  J Low Genit Tract Dis       Date:  2022-05-05       Impact factor: 3.842

Review 5.  Vulvar skin disorders throughout lifetime: about some representative dermatoses.

Authors:  Jean Doyen; Stéphanie Demoulin; Katty Delbecque; Frédéric Goffin; Frédéric Kridelka; Philippe Delvenne
Journal:  Biomed Res Int       Date:  2014-01-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.